🇺🇸 Atorvastatin A in United States

9 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bacterial Infection — 1 report (11.11%)
  2. Biliary Sepsis — 1 report (11.11%)
  3. Cholangitis — 1 report (11.11%)
  4. Cholecystitis — 1 report (11.11%)
  5. Cholelithiasis — 1 report (11.11%)
  6. Gallbladder Disorder — 1 report (11.11%)
  7. Ileus — 1 report (11.11%)
  8. Pancreatitis — 1 report (11.11%)
  9. Post Procedural Complication — 1 report (11.11%)

Source database →

Atorvastatin A in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Atorvastatin A approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Atorvastatin A in United States?

Hanmi Pharmaceutical Company Limited is the originator. The local marketing authorisation holder may differ — check the official source linked above.